The impact of Hurricane Helene has led to a temporary supply disruption at the Baxter facility in Marion, North Carolina. The facility manufactures a significant portion of IV solutions, irrigation ...
The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for elinzanetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.
The Food and Drug Administration (FDA) has granted Fast Track designation to liafensine (DB104) for patients with treatment-resistant depression (TRD).